• Redcliffe Labs has issued a COVID-19 advisory urging early testing, medical consultation, and preventive measures amid rising cases in India.
• The lab recommends RT-PCR and RATs for accurate and quick diagnosis, especially for symptomatic or high-risk individuals.
• With a robust network across India, Redcliffe Labs is prepared to handle increased testing and continues to provide reliable, accessible diagnostics.

In response to a recent uptick in COVID-19 cases across parts of India, Redcliffe Labs, a prominent omnichannel diagnostics provider, has issued a healthcare advisory that encourages the public to remain cautious and responsible. With national case numbers surpassing 250 in May 2025, the advisory highlights the importance of early testing, seeking medical advice, and following preventive guidelines.

The company has analyzed current trends regarding respiratory infections and suggests that individuals showing symptoms such as fever, coughing, cold, or fatigue should promptly consult a healthcare professional and consider getting tested. It also recommends that asymptomatic individuals who have had close contact with confirmed or suspected cases exercise caution and adhere to local health regulations.

“While there is a resurgence in a few regions, the situation remains manageable. There is no need for panic. What’s important is timely action. We advise individuals not to ignore early symptoms such as cough, fever, or severe body aches. Consult a doctor if you feel unwell, get tested if needed, and take basic precautions. At Redcliffe Labs, we remain committed to supporting communities with accessible diagnostics and reliable health information”, said Dr. Mayanka Lodha Seth, Chief Pathologist at Redcliffe Labs.

Redcliffe Labs advocates for molecular testing like RT-PCR due to its high accuracy in identifying the virus’s genetic makeup. Additionally, Rapid Antigen Tests (RATs) are available for quicker results and are particularly beneficial for symptomatic individuals or those with high-risk exposure. While waiting for test results, the advisory emphasizes wearing masks and reducing close interactions to lower the chances of transmission. Redcliffe Labs has reassured the public of its capability to manage an increase in testing demands through its extensive network of laboratories and collection centers throughout India. In line with its dedication to public health, Redcliffe Labs continues to offer accessible diagnostic services and timely health updates, supported by advanced infrastructure and strict quality standards.